Adenoviral RB2/p130 gene transfer inhibits smooth muscle cell proliferation and prevents restenosis after angioplasty

Circulation Research

Volumn 85, Issue 11, 1999, Pages 1032-1039

  Claudio, Pier Paolo ^a,c,j   Fratta, Luigi ^d   Farina, Felicia ^f   Howard, Candace M ^a   Stassi, Giorgio ^e,f   Numata, Shin Ichiro ^j   Pacilio, Carmen ^a   Davis, Alan ^g   Lavitrano, Marialuisa ^h   Volpe, Massimo ^d,h   Wilson, James M ^g   Trimarco, Bruno ^d,i   Giordano, Antonio ^a   Condorelli, Gianluigi ^b,h,j  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d IRCCS NEUROMED   (Italy)

^e CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^f UNIVERSITY OF PALERMO   (Italy)

^g WISTAR INSTITUTE   (United States)

^h SAPIENZA UNIVERSITY OF ROME   (Italy)

ⁱ UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^j NONE

more..

Author keywords

Adenovirus; Cell cycle; Gene therapy; P130; PRb2; Restenosis

Indexed keywords

VIRUS VECTOR;

ADENOVIRUS; ANGIOPLASTY; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL MIGRATION; CELL PROLIFERATION; CORONARY ARTERY DISEASE; GENE THERAPY; GENE TRANSFER; GROWTH INHIBITION; HUMAN; HUMAN CELL; MULTIGENE FAMILY; PRIORITY JOURNAL; RESTENOSIS; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TRANSCRIPTION REGULATION;

EID: 0033607780     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.85.11.1032     Document Type: Article

References (27)

1. Clowes AW, Reidy MA, Clowes MM. Mechanisms of stenosis after arterial injury. Lab Invest. 1983;49:208-215.
2. Libby P, Schwartz D, Brogi E, Tanaka H, Clinton SK. A cascade model for restenosis: a special case of atherosclerosis progression. Circulation. 1992;86(suppl III):III-47-III-52.
3. Morishita R, Gibbons GH, Ellison KE, Nakajima M, Zhang L, Kaneda Y, Ogihara T, Dzau VJ. Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. Proc Natl Acad Sci U S A. 1993;90: 8474-8478.
4. Chang MW, Barr E, Seltzer J, Jiang YQ, Nabel GJ, Nabel EG, Parmacek MS, Leiden JM. Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science. 1995;267:518-522.
5. Smith RC, Wills KN, Antelman D, Perlman H, Truong LN, Krasinski K, Walsh K. Adenoviral constructs encoding phosphorylation-competent full-length and truncated forms of the human retinoblastoma protein inhibit myocyte proliferation and neointima formation. Circulation. 1997; 96:1899-1905. See comments.
6. Weinberg RA. E2F and cell proliferation: a world turned upside down. Cell. 1996;85:457-459.
7. Nevins JR, Leone G, DeGregori J, Jakoi L. Role of the Rb/E2F pathway in cell growth control. J Cell Physiol. 1997;173:233-236.
8. Claudio PP, Howard CM, Baldi A, De Luca A, Fu Y, Condorelli G, Sun Y, Colburn N, Calabretta B, Giordano A. p130/pRb2 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107. Cancer Res. 1994;54:5556-5560.
9. Claudio PP, De Luca A, Howard CM, Baldi A, Firpo EJ, Koff A, Paggi MG, Giordano A. Functional analysis of pRb2/p130 interaction with cyclins. Cancer Res. 1996;56:2003-2008.
10. De Luca A, MacLachlan TK, Bagella L, Dean C, Howard CM, Claudio PP, Baldi A, Khalili K, Giordano A. A unique domain of pRb2/p130 acts as an inhibitor of Cdk2 kinase activity. J Biol Chem. 1997;272: 20971-20974.
11. Indolfi C, Avvedimento EV, Rapacciuolo A, Di Lorenzo E, Esposito G, Stabile E, Feliciello A, Mele E, Giuliano P, Condorelli G. Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo. Nat Med. 1995;1:541-545. See comments.
12. Indolfi C, Avvedimento EV, Di Lorenzo E, Esposito G, Rapacciuolo A, Giuliano P, Grieco D, Cavuto L, Stingone AM, Ciullo I, Condorelli G, Chiariello M. Activation of cAMP-PKA signaling in vivo inhibits smooth muscle cell proliferation induced by vascular injury. Nat Med. 1997;3:775-779.
13. Davis AR, Wilson JM. Adenoviral vectors. In: Current Protocols in Human Genetics. New York, NY: John Wiley & Sons, Inc; 1996.
14. Rothman A, Kulik TJ, Taubman MB, Berk BC, Smith CW, Nadal-Ginard B. Development and characterization of a cloned rat pulmonary arterial smooth muscle cell line that maintains differentiated properties through multiple subcultures. Circulation. 1992;86: 1977-1986.
15. Davis AR, Meyers K, Wilson JM. High output method for creating and screening recombinant adenoviruses. Gene Therapy. 1998;5:1148-1152.
16. Arad U. Modified Hirt procedure for rapid purification of extrachromosomal DNA from mammalian cells. Biotechniques. 1998;24: 760-762.
17. Pagano M, Draetta G, Jansen-Durr P. Association of cdk2 kinase with the transcription factor E2F during S phase. Science. 1992;255: 1144-1147.
18. De Luca A, Baldi A, Esposito V, Howard CM, Bagella L, Rizzo P, Caputi M, Pass HI, Giordano GG, Baldi F, Carbone M, Giordano A. The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas. Nat Med. 1997;3: 913-916. See comments.
19. Dixon WJ, Massey JJ. Introduction to Statistical Analysis. New York, NY: McGraw-Hill; 1969.
20. Roberts GC, Gooding C, Smith CW. Smooth muscle alternative splicing induced in fibroblasts by heterologous expression of a regulatory gene. EMBO J. 1996;15:6301-6310.
21. Sardet C, Vidal M, Cobrinik D, Geng Y, Onufryk C, Chen A, Weinberg RA. E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc Natl Acad Sci U S A. 1995;92: 2403-2407.
22. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell. 1995;81:323-330.
23. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
24. Howard CM, Claudio PP, Gallia GL, Gordon J, Giordano GG, Hauck WW, Khalili K, Giordano A. Retinoblastoma-related protein pRb2/p130 and suppression of tumor growth in vivo. J Natl Cancer Inst. 1998;90: 1451-1460.
25. Neuman E, Flemington EK, Sellers WR, Kaelin WGJ. Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter. Mol Cell Biol. 1994;14:6607-6615.
26. Cobrinik D, Whyte P, Peeper DS, Jacks T, Weinberg RA. Cell cycle-specific association of E2F with the p 130 E1A-binding protein. Genes Dev. 1993;7:2392-2404.
27. Moberg K, Starz MA, Lees JA. E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol Cell Biol. 1996;16: 1436-1449.